Skip to Main Content

Seminars 2016-2017

Connect with CMS

Cellular & Molecular Pharmacology

September 7, 2016
11:00 a.m.
Daniel Lodge, PhD
University of Texas San Antonio
San Antonio, TX
Novel Therapeutic Interventions for Schizophrenia: Preclinical Data From Rodent Models
October 5, 2016
11:00 a.m.
Robert Nagele, PhD
Rowan University School of Osteopathic Medicine
New Brunswick, NJ
Early Detection of Neurodegenerative Diseases Using Blood-based Biomarkers
November 9, 2016
11:00 a.m.
François Georges, PhD
Bordeaux University
Bordeaux, France
NMDAR-dependent Plasticity in the Bed Nucleus of the Stria Terminalis Triggers Long-term Anxiolysis
November 18, 2016
11:00 a.m.
Christelle Baunez, PhD
University of Marseille
Marseille, France
Subthalamic Nucleus as the Appropriate Target for Deep Brain Stimulation Treatment of Addiction
November 30, 2016
11:00 a.m.
Mark S. Brodie, PhD
University of Illinois at Chicago
Chicago, IL
Ethanol Actions in the Ventral Tegmental Area: Epigenetic Mechanism and Novel Targets
January 4, 2017
11:00 a.m.
Robert Froemke, PhD
New York University School of Medicine
New York, NY
Oxytocin, Maternal Behavior, and Synaptic Plasticity
January 26, 2017
11:00 a.m.
Thomas Bozza, PhD
Northwestern University
Evanston, IL
Genetic Analysis of Olfactory Perception in the Mouse
February 22, 2017
11:00 a.m.
Eugene Dimitrov, PhD
Rosalind Franklin University
North Chicago, IL
Amygdala CRF Neurons Contribution to
Stress-induced Analgesia and Chronic Pain
March 29, 2017
11:00 a.m.
Paul Marvar, PhD
The George Washington University
Washington, DC
Angiotensin II as a Mediator of Fear Memory: Implications for PTSD related Cardiovascular Dysfunction
April 26, 2017
11:00 a.m.

May 24, 2017
11:00 a.m.
J. Amiel Rosenkranz, PhD
Rosalind Franklin University
North Chicago, IL
Is Socialization Important for the Amygdala and Emotion?

Current SeminarsSeminars 2018-2019Seminars 2017-2018